Nisha Holay

3PUBLICATIONS
27CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|May 22, 2025
INBRX-106: a hexavalent OX40 agonist that drives superior antitumor responses via optimized receptor clustering.

|Apr 09, 2025
The response to anti-PD-1 and anti-LAG-3 checkpoint blockade is associated with regulatory T cell reprogramming.

Annah S Rolig, Xiyu Peng, Elizabeth R Sturgill

|Aug 17, 2022
Covalent JNK Inhibitor, JNK-IN-8, Suppresses Tumor Growth in Triple-Negative Breast Cancer by Activating TFEB- and TFE3-Mediated Lysosome Biogenesis and Autophagy.

Milad Soleimani, Alexander Somma, Tamer Kaoud

Pageof 1

Frequent Collaborators

2 joint publications

William L Redmond

2 joint publications

Annah S Rolig

1 joint publications

Milad Soleimani

1 joint publications

Alexander Somma